Breaking News Instant updates and real-time market news.

F

Ford

$9.46

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:42
08/14/18
08/14
09:42
08/14/18
09:42

Ford-owned Autonomic announces partnership with Alibaba Cloud

Autonomic, a wholly owned subsidiary of Ford Smart Mobility LLC (F), and Alibaba Cloud, the cloud computing arm of Alibaba Group (BABA), signed a Memorandum of Understanding to bring to China the Transportation Mobility Cloud. Enabled by Alibaba Cloud, the TMC will serve as an open, cloud-based platform that provides standardized data and infrastructure for developers to quickly build value-added software programs for interacting with connected vehicles. This new software could help deliver a better in-vehicle connectivity and mobility experience for Chinese consumers, such as helping residents plan transit journeys, managing a large-scale fleet for a ride-hailing business, and even routing self-driving cars on busy streets. Autonomic and Alibaba Cloud believe this partnership will be instrumental in shaping China's transportation ecosystem by empowering multiple parties - including automakers, public transit operators and large-scale fleet operators and software developers - to enhance their vehicle connectivity and mobility experiences for Chinese customers. Both companies also agreed to explore new collaboration opportunities in the transportation and mobility sectors, with the ultimate goal of creating a safer, more efficient and sustainable transportation ecosystem in China.

F

Ford

$9.46

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

  • 15

    Aug

  • 23

    Aug

  • 31

    Aug

  • 10

    Sep

F Ford
$9.46

(0.00%)

07/20/18
JPMS
07/20/18
NO CHANGE
JPMS
Overweight
JPMorgan says buy GM, sell Tesla into Q2 earnings reports
JPMorgan analyst Ryan Brinkman forecasts lower than consensus Q2 earnings for Ford (F) and higher than Street earnings for General Motors (GM). Both companies are likely to be impacted by higher commodity costs during the quarter, although the decline in spot prices subsequent to the quarter should limit impact to the full year, Brinkman tells investors in a research note previewing the Q2 earnings for the automakers. The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintains Overweight ratings on GM and Ford, with a preference for GM shares. He also keeps his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
07/20/18
07/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS YUM CHINA TO UNDERPERFORM: BofA Merrill Lynch analyst Chen Luo downgraded Yum China (YUMC) to Underperform from Neutral and cut its price target to $34 from $44.30. Luo said he expects Yum China to continue to underperform given a likely peak in KFC trends amid China's weakening macro environment, a likely prolonged turnaround at Pizza Hut combined with heavy costs, a slowdown in Chinese consumer consumption, and RMB depreciation. Yum China is down 4.8% in late morning trading. CREDIT SUISSE CUTS FIVE BELOW TO NEUTRAL: Credit Suisse analyst Judah Frommer downgraded Five Below (FIVE) to Neutral from Outperform, telling investors that he is moving to the sidelines as he sees risk/reward balanced at current levels given the stock's material outperformance and back-half comp acceleration that he believes is priced into shares. Frommer keeps his $110 price target and says Five Below remains one of the most differentiated concepts in retail. Five Below is down 4.4% in late morning trading. BAIRD MORE CAUTIOUS ON DRUG SUPPLY CHAIN: Baird analyst Eric Coldwell downgraded Express Scripts (ESRX), AmerisourceBergen (ABC), and McKesson (MCK), all to Neutral from Outperform, citing the heavy political attack in recent weeks against pharmacy benefit managers and members of the drug supply chain. Among them, he said AmerisourceBergen remains his preferred name, but he cannot justify putting new money to work in these names in the current environment. SUNTRUST STARTS VIKING WITH A BUY: SunTrust analyst Edward Nash initiated Viking Therapeutics (VKTX) with a Buy rating and a price target of $14, saying its VK2809 drug for lipid disorders "has the potential to become a promising treatment by addressing multiple metabolic issues" associated with the non-alcoholic steatohepatitis disease, or NASH. Viking is up 8.3% in late morning trading. JPMORGAN SAYS BUY GM, SELL TESLA INTO EARNINGS: JPMorgan analyst Ryan Brinkman forecast lower than consensus Q2 earnings for Ford (F) and higher than consensus earnings for General Motors (GM). The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla (TSLA) in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintained Overweight ratings on GM and Ford, with a preference for GM shares. He also kept his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $57
PIPR
Overweight
General Motors outperforming Ford in China, says Piper Jaffray
While both would suffer in a trade war, it is clear that General Motors (GM) is outperforming Ford (F) in China, Piper Jaffray analyst Alexander Potter tells investors in a research note. The analyst views GM's China business as stable, with a growing presence in luxury. He thinks Cadillac represented 16.7% of GM's Q2 revenue in China, versus 13.6% in 2017, which should boost margins. Until its "new product blitz gains momentum, Ford's China business will likely continue bleeding," Potter contends. He notes the company's Ford's retail sales in China declined by 38% year-over-year in June. The analyst keeps an Overweight rating on GM and a Neutral rating on Ford.
08/14/18
NOMU
08/14/18
NO CHANGE
Target $9
NOMU
Neutral
Ford price target lowered to $9 from $10 at Nomura Instinet
Nomura Instinet analyst Anindya Das lowered his price target for Ford to $9 after reducing fiscal 2018 earnings per share estimate by 17% to $1.20. The analyst lowered his outlook for Ford's Asia Pacific operations based on first half of 2018 sales trends and also sees Europe becoming more difficult. Das keeps a Neutral rating on Ford shares.
BABA Alibaba
$177.65

(0.00%)

07/06/18
RHCO
07/06/18
NO CHANGE
Target $215
RHCO
Buy
Alibaba price target lowered to $215 from $235 at SunTrust
SunTrust analyst Youssel Squali lowered his price target on Alibaba to $215, citing the impact of later than expected closing for Ele.me, whose $9.5B acquisition was announced in early April. The analyst is also tempering his expectations for growth in the Cloud segment while noting the adverse impact of the recent USD strength relative to the Renminbi. Longer term, Squali keeps his Buy rating on Alibaba, pointing to "exciting initiatives" around Ant Financial's new funding at $150B, exclusive online broadcasting rights of the World Cup, and promising initiatives around enterprise and voice.
07/09/18
DADA
07/09/18
NO CHANGE
Target $8
DADA
Buy
Groupon offers 'tremendous value' in potential sale, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon following speculation by Recode over the weekend that the company is looking to sell itself. Forte recommends that investors purchase shares, stating that the market is underpricing Groupon as its "North American business has never been in better shape and its international operations are well positioned". In a bull case, the analyst contends that Groupon could be worth $12 per share if it can improve its growth rate or find a strategic buyer where a deal would value the two companies higher than the sum of their parts. Forte speculates about Priceline (PCLN), Alibaba (BABA), Google (GOOGL), and Facebook (FB) as potential acquirers for Groupon.
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
08/14/18
MKMP
08/14/18
NO CHANGE
Target $51
MKMP
Buy
JD.com has 'improving event path' and 'low valuation', says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $51 price target on JD.com (JD) ahead of its Q2 earnings this week, saying that while consensus expectations suggest concern with whether net margins can achieve the 0.9%, more bullish investors can be rewarded beyond this quarter. The analyst further notes that the loss of market share to Alibaba (BABA), along with China macro trade concerns, have weighed on the stock, but its "all-time low" valuation is compelling, and even a partial recovery in performance could yield a sizable move in the stock price.

TODAY'S FREE FLY STORIES

RMD

ResMed

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Upgrade
ResMed rating change  »

ResMed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$109.97

-2.38 (-2.12%)

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Upgrade
ResMed rating change  »

ResMed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Recommendations
Gilead analyst commentary  »

Gilead landing Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$109.97

-2.38 (-2.12%)

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Upgrade
ResMed rating change  »

ResMed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGEN

Compugen

$3.30

-0.16 (-4.62%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Compugen management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MNLO

Menlo Therapeutics

$5.69

0.13 (2.34%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Menlo Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

EBIX

Ebix

$47.17

0.24 (0.51%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Hot Stocks
Ebix division to provide foreign exchange services at India airport »

Ebix announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

NRG

NRG Energy

$40.53

-0.01 (-0.02%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Recommendations
NRG Energy analyst commentary  »

NRG Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$7.30

-0.4 (-5.19%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Hot Stocks
Tronox confirms decision by FTC judge regarding pending Cristal acquisition »

Tronox confirmed receipt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCMP

Cabot Microelectronics

$96.77

-4.7 (-4.63%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Conference/Events
Cabot Microelectronics management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$168.37

-6.37 (-3.65%)

, BAC

Bank of America

$25.43

-0.86 (-3.27%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$168.37

-6.37 (-3.65%)

BAC

Bank of America

$25.43

-0.86 (-3.27%)

ATVI

Activision Blizzard

$47.21

-0.94 (-1.95%)

ET

Energy Transfer LP

$14.26

0.03 (0.21%)

DE

Deere

$147.27

-7.01 (-4.54%)

QD

Qudian

$4.97

-0.04 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

COP

ConocoPhillips

$65.93

-0.68 (-1.02%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Hot Stocks
ConocoPhillips sets FY19 CapEx budget of $6.1B »

ConocoPhillips has set a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SKY

Skyline

$17.59

-0.67 (-3.67%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Conference/Events
Skyline management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

PG

Procter & Gamble

$92.45

-1.08 (-1.15%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Recommendations
Procter & Gamble analyst commentary  »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

SMLP

Summit Midstream

$12.72

-0.05 (-0.39%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Hot Stocks
Summit Midstream CFO Matthew Harrison to depart »

Summit Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$65.93

-0.68 (-1.02%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
ConocoPhillips sees 2019 production of 1,300-1,350 MBOED »

ConocoPhillips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ONTX

Onconova

$3.47

-0.29 (-7.71%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
Onconova names Avi Oler as VP, corporate development and general counsel »

Onconova Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MITK

Mitek Systems

$8.98

-0.12 (-1.32%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
ASG Technologies increases offer to $11.50 per share to acquire Mitek Systems »

ASG Technologies made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$6.00

-0.1 (-1.64%)

07:31
12/10/18
12/10
07:31
12/10/18
07:31
Upgrade
Synchronoss rating change  »

Synchronoss upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$26.99

-0.62 (-2.25%)

, SPLK

Splunk

$105.70

-5.43 (-4.89%)

07:30
12/10/18
12/10
07:30
12/10/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPS

Gap

$26.99

-0.62 (-2.25%)

SPLK

Splunk

$105.70

-5.43 (-4.89%)

ON

ON Semiconductor

$17.37

-0.91 (-4.98%)

AEO

American Eagle

$18.96

-0.81 (-4.10%)

EQT

EQT Corporation

$18.42

0.41 (2.28%)

NYT

New York Times

$25.11

-0.8 (-3.09%)

TER

Teradyne

$32.60

-1.18 (-3.49%)

USAT

USA Technologies

$4.22

-0.18 (-4.09%)

KAR

KAR Auction

$51.04

-3.17 (-5.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

  • 03

    Mar

  • 08

    May

AUY

Yamana Gold

$2.26

0.075 (3.43%)

07:29
12/10/18
12/10
07:29
12/10/18
07:29
Downgrade
Yamana Gold rating change  »

Yamana Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCM

R1 RCM

$8.71

-0.31 (-3.44%)

07:29
12/10/18
12/10
07:29
12/10/18
07:29
Initiation
R1 RCM initiated  »

R1 RCM initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$137.42

-2.14 (-1.53%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Recommendations
Facebook analyst commentary  »

Facebook valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$10.82

0.2 (1.88%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Hot Stocks
Voyager Therapeutics doses first patient in RESTORE-1 trial »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$27.56

-1.85 (-6.29%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Conference/Events
Vanda Pharmaceuticals to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.